|
⚲
|
| Keyboard |
| Northpond Ventures LLC
✚
|
|
|---|---|
| CRD # | 297265 |
| SEC # | 802-113525 |
| CIK # | 0001911245, 0001867472 |
| AUM | |
| Employees | |
| Fees | |
| Minimum | |
| Phone | 240-800-1200 |
| Address | 7500 Old Georgetown Rd Bethesda, MD 20814 |
| Source | [IAPD] [EDGAR] [Website] [LinkedIn] [Instagram] |
| Total AUM ($) |
|---|
| Sector | Form 13F Holdings | Value ($M) | |
|---|---|---|---|
| Kyverna Therapeutics Inc | 15.9 | ||
| Candel Therapeutics Inc | 13.4 | ||
| Holdings by Sector ($M) |
|---|
| Type | Form D Funds | Date | Sold | AUM |
|---|---|---|---|---|
| VC | Northpond Foundry Fund I LP | [2025-03-28] | 199.8 M | |
| Filed 2024-08-15 (D) · Exemption 506(b), 3(c), 3(c)(1), 3(c)(7) · Remaining Indefinite · Duration One year or less · Revenue Decline to Disclose | ||||
| VC | Northpond Ventures III LP | 2022-03-31 | 560.6 M | |
| VC | Northpond Capital LP | 2021-03-29 | 314.8 M | |
| VC | Northpond Ventures II LP | 2021-03-29 | 297.9 M | |
| VC | Northpond Ventures LP | 2018-05-31 | 338.1 M | |
| AUM Breakdown | Accounts | AUM ($) |
|---|---|---|
| By Client Type | ||
| (a) Individuals (other than high net worth individuals) | 0 | 0.0 |
| (b) Individuals (high net worth individuals) | 0 | 0.0 |
| (c) Banking or thrift institutions | 0 | 0.0 |
| (d) Investment companies | 0 | 0.0 |
| (e) Business development companies | 0 | 0.0 |
| (f) Pooled investment vehicles | 0 | 0.0 |
| (g) Pension and profit sharing plans | 0 | 0.0 |
| (h) Charitable organizations | 0 | 0.0 |
| (i) State or municipal government entities | 0 | 0.0 |
| (j) Other investment advisers | 0 | 0.0 |
| (k) Insurance companies | 0 | 0.0 |
| (l) Sovereign wealth funds and foreign official institutions | 0 | 0.0 |
| (m) Corporations or other businesses not listed above | 0 | 0.0 |
| (n) Other | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Discretionary | ||
| Discretionary | 0 | 0.0 |
| Non-Discretionary | 0 | 0.0 |
| Total | 0 | 0.0 |
| By Non-United States Persons | ||
| Non-United States Persons | 0.0 | |
| United States Persons | 0.0 | |
| Total | 0 | 0.0 |
| Form D Directors | Role | # Filings | # Firms | 2011 - 2026 |
|---|---|---|---|---|
| Michael Rubin | Director | 42 | 3 | |
| Northpond Foundry Fund I GP LLC | Executive Officer | 1 | 1 | |
| Northpond Ventures LLC | Director | 1 | 1 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001867472] | |
| 4 | [0001867472] | |
| SC 13D | [0001867472] | |
| SC 13G | [0001867472] | |
| 13F-HR | [0001911245] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 1,003,193 | ||
|
Camp4 Therapeutics Corp CAMP
Series B Preferred Stock · derivative
|
2024-10-15 | Conversion | 5,287,303 | ||
|
Camp4 Therapeutics Corp CAMP
Series A Prime Preferred Stock · derivative
|
2024-10-15 | Conversion | 11,251,624 | ||
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Buy | 763,636 | $11.00 | 8,399,996 |
|
Camp4 Therapeutics Corp CAMP
Common Stock
|
2024-10-15 | Conversion | 471,415 | ||
|
DiCE Molecules Holdings LLC DICE
Common Stock
|
2023-06-22 | Sell | 523,503 | $46.50 | 24,342,890 |
|
DiCE Molecules Holdings LLC DICE
Common Stock
|
2023-06-22 | Sell | 1,969,368 | $46.50 | 91,575,612 |
|
Telesis Bio Inc TBIO
Redeemable Convertible Preferred Stock · derivative
|
2023-06-05 | Grant | 80,000 | $100.00 | 8,000,000 |
|
Telesis Bio Inc TBIO
Long-Term Warrants · derivative
|
2023-06-05 | Grant | 3,385,097 | $0.00 | |
|
Telesis Bio Inc TBIO
Short-Term Warrants · derivative
|
2023-06-05 | Grant | 1,692,549 | $0.00 | |
|
Vigil Neuroscience Inc VIGL
Series B Preferred Stock · derivative
|
2022-01-11 | Conversion | 1,027,978 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Buy | 355,000 | $14.00 | 4,970,000 |
|
Vigil Neuroscience Inc VIGL
Series A Preferred Stock · derivative
|
2022-01-11 | Conversion | 2,831,520 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 1,027,978 | ||
|
Vigil Neuroscience Inc VIGL
Common Stock
|
2022-01-11 | Conversion | 2,831,520 | ||
|
IsoPlexis Corp ISO
Common Stock
|
2021-10-12 | Buy | 1,000,000 | $15.00 | 15,000,000 |
|
IsoPlexis Corp ISO
Series C Redeemable Convertible Preferred Stock · derivative
|
2021-10-12 | Conversion | 287,785 | $0.00 | |
|
IsoPlexis Corp ISO
Series D Redeemable Convertible Preferred Stock · derivative
|
2021-10-12 | Conversion | 130,006 | $0.00 | |
|
IsoPlexis Corp ISO
Series C-2 Redeemable Convertible Preferred Stock · derivative
|
2021-10-12 | Conversion | 309,131 | $0.00 | |
|
IsoPlexis Corp ISO
Series D Redeemable Convertible Preferred Stock · derivative
|
2021-10-12 | Conversion | 191,108 | $0.00 | |
| showing 20 of 32 most recent transactions | |||||